FindTrial
Sign In

Evaluation of anticancer activity of Patha in breast and cervical cancer cell line.

Evaluation of cytotoxic activity of Patha (Cissampelos pareira Linn.) root extracts prepared by two methods (Soxhlet and Super critical) on Cancer Cell Lines (Breast and Cervical). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064009
Enrollment
30
Registered
2024-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HEALTHY VOLUNTEERS

Exclusion criteria

Exclusion criteria: NOT WILLING TP PARTICIPATE IN THE STUDY

Design outcomes

Primary

MeasureTime frame
Ras Pariksha Protocol analysis. Timepoint: Ras Pariksha Protocol analysis.—

Secondary

MeasureTime frame
Assessment of occurrence of adverse event.Timepoint: NA—

Countries

India

Contacts

Public ContactDr Shivani Ghildiyal

All India Institute Of Ayurveda,New Delhi

tnesari@hotmail.com9958817145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026